Targeted RNA-based therapies for Mucopolysaccharidosis
Over the last years, most of our work has been focused on the development of alternative, RNAbased therapies for a number of Lysosomal Storage Disorders (LSD), being Mucopolysaccharidosis (MPS) one of the most relevant. Currently, there are two major research lines being pursued: the first relies on...
Main Author: | |
---|---|
Other Authors: | , , , , , , , |
Format: | conferenceObject |
Language: | eng |
Published: |
2022
|
Subjects: | |
Online Access: | http://hdl.handle.net/10400.18/8146 |
Country: | Portugal |
Oai: | oai:repositorio.insa.pt:10400.18/8146 |